Offer - Urjas Oil for just ₹ 1 X
Tilemetin 30 Injection is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Amebiasis.
Medical history of the patient along with age and gender determines the dosage of Tilemetin 30 Injection. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Tilemetin 30 Injection include Headache, Nausea or vomiting, Weakness. Apart from the aforementioned side effects, Tilemetin 30 Injection can also lead to other problems, which have been listed below. Such side effects of Tilemetin 30 Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Tilemetin 30 Injection's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Tilemetin 30 Injection's effects on the liver, heart and kidney are discussed below in the Tilemetin 30 Injection related warnings section.
Some other conditions that can be affected by Tilemetin 30 Injection are listed in the contraindications section below.
Drug reaction of Tilemetin 30 Injection with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Tilemetin 30 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Tilemetin 30 Injection is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Neonates (0 to 1 month) |
|
Is the use of Tilemetin 30 Injection safe for pregnant women?
Tilemetin may have some side effects during pregnancy. Pregnant women should discontinue the use of Tilemetin, and talk to their doctor, if they notice any discomfort.
Is the use of Tilemetin 30 Injection safe during breastfeeding?
Breastfeeding women may feel side effects of Tilemetin. If you see any side effects, stop taking Tilemetin immediately and talk to your doctor. Take Tilemetin again, only after your doctor's advice.
What is the effect of Tilemetin 30 Injection on the Kidneys?
Tilemetin has very mild side effects on the kidneys.
What is the effect of Tilemetin 30 Injection on the Liver?
So far, no research has been carried out on the effects of Tilemetin on the liver. So it is not known whether taking Tilemetin will affect the liver or not.
What is the effect of Tilemetin 30 Injection on the Heart?
Very few cases of side effects of Tilemetin on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Tilemetin 30 Injection unless your doctor advises you to do so -
Is this Tilemetin 30 Injection habit forming or addictive?
Tilemetin 30 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Tilemetin 30 Injection. So it is best to avoid driving.
Is it safe?
Tilemetin 30 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Tilemetin 30 Injection cannot treat any kind of mental disorder.
Interaction between Food and Tilemetin 30 Injection
Due to a lack of research, nothing can be said about the consequences of taking Tilemetin 30 Injection together with food.
Interaction between Alcohol and Tilemetin 30 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Tilemetin 30 Injection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 840